The Debrief: Conn Carroll on dueling rulings on FDA-approved abortion pill

By Washington Examiner
.

Abortion Pill
FILE – Bottles of the drug misoprostol sit on a table at the West Alabama Women’s Center, March 15, 2022, in Tuscaloosa, Ala. Misoprostol induces uterus contractions that expel an embryo or fetus and other tissue. A federal judge in Texas will hear arguments Wednesday, March 15, 2023, in a high-stakes court case that could threaten access to abortion medication and blunt the authority of U.S. drug regulators. The lawsuit from Christian conservatives aimed at overturning the Food and Drug Administration’s approval of the abortion pill mifepristone. The drug, when used with a second pill, misoprostol, has become the most common method of abortion in the U.S. (AP Photo/Allen G. Breed, File) Allen G. Breed/AP

The Debrief: Conn Carroll on dueling rulings on FDA-approved abortion pill

Video Embed

Washington Examiner Commentary Editor Conn Carroll joins Sarah Westwood to discuss the two conflicting rulings on the abortion pill approved by the Food and Drug Administration and what the outcome may be if it heads to the Supreme Court.

© 2023 Washington Examiner

Related Content

Copyright 2024. Washington Examiner. All Rights Reserved.